A contract research organization (CRO) is a specialized service provider that offers critical support to the pharmaceutical sector. Within a CRO, various departments work cohesively to ensure the seamless execution of clinical trials or bioanalytical/bioequivalence (BA/BE) studies. Among these roles, a pharmacologist is responsible for evaluating the medical components of study protocols and ensuring participant safety. Over the last 10 years, India has emerged as a preferred location for global clinical research, attracting numerous international pharmaceutical firms. The contract research industry in India operates under strict scrutiny, with auditors and regulatory inspectors closely monitoring all processes. As per the Clinical Trials Registry-India (CTRI), it is mandatory to register all clinical trials conducted in the country at no cost. This registration must be completed before enrolling the first participant. In a CRO, a pharmacologist often serves as an investigator or principal investigator, overseeing trial conduct. India’s prominence as a clinical research hub for multinational pharmaceutical companies stems from multiple advantages. However, despite the growing interest in global clinical research, Indian CROs face certain challenges. Maintaining ethical business practices is crucial, as it fosters trust and strengthens partnerships with sponsors and collaborators.